Sisram Medical

Sisram Medical FCF/Debt

The Free Cash Flow to Debt Ratio of Sisram Medical (1696.HK) as of Oct 28, 2026 is 13.17 %. In the previous year, Free Cash Flow to Debt Ratio was 8.97 % — a change of 46.82% (higher).

FCF/Debt

13.17 %

YoY

46.82%

Last updated:

Free Cash Flow to Debt Ratio of Sisram Medical is 2025 13.17 % . Free Cash Flow to Debt Ratio of Sisram Medical was 2024 8.97 % . It decreases by 46.82% higher compared to the previous year.

The Sisram Medical FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2018
689.54 USD
Jan 1, 2019
192.49 USD
Jan 1, 2020
48.07 USD
Jan 1, 2021
70.67 USD
Jan 1, 2022
-102.28 USD
Jan 1, 2023
79.15 USD
Jan 1, 2024
8.97 USD
Jan 1, 2025
13.17 USD
The Sisram Medical FCF/Debt history
YEARFCF/DebtYoY
13.17 %+46.82%
8.97 %-88.67%
79.15 %-177.39%
-102.28 %-244.74%
70.67 %+47.00%
48.07 %-75.03%
192.49 %-72.08%
689.54 %+432.29%
129.54 %+408.37%
25.48 %+3.07%
24.72 %-24.71%
32.84 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sisram Medical Stock analysis

What does Sisram Medical do? Sisram Medical Ltd is a leading company in the field of medical technologies and offers innovative solutions in aesthetic and medical laser treatments. The company is headquartered in Israel and operates in over 100 countries worldwide. The history of Sisram Medical dates back to 1997 when the company El.En SpA was founded in Italy. El.En SpA is a global leading manufacturer of medical lasers and specializes in the production of laser systems. In 2013, the company became part of Shanghai Fosun Pharmaceutical Group Co., Ltd and Sisram Medical was established. The business model of Sisram Medical is based on the development and manufacturing of innovative medical laser systems. The company is divided into two main divisions: aesthetic and medical. The aesthetic division includes products for skin rejuvenation, hair removal, and body contouring. The medical division offers products for the treatment of skin diseases such as psoriasis, as well as medical laser systems for tumor removal and the treatment of gynecological and urological conditions. Among the products offered by Sisram Medical is the Harmony XL Pro System. This system is a versatile laser system used for the treatment of acne, pigmentation disorders, and wrinkles. The Soprano ICE Platinum Laser hair removal technology is also a popular method for permanently getting rid of unwanted hair. The V-Lase system is another product innovation from Sisram Medical and is used for the treatment of vaginal issues. Another important division of Sisram Medical is the medical laser systems. These systems are used for the treatment of various skin conditions such as psoriasis and eczema. The MonaLisa Touch system is another medical laser system used for the treatment of vaginal discomfort. Sisram Medical stands out from other medical laser manufacturers with its intensive research and development. The company conducts continuous research to develop new products and improve existing ones. It works closely with leading medical professionals to ensure that its laser systems meet the highest quality standards. Overall, Sisram Medical Ltd is an innovative company specializing in the development and manufacturing of medical laser systems. It offers products and solutions for aesthetic and medical applications and operates worldwide. Through intensive research and collaboration with experts, the company is able to offer high-quality products that meet the needs of customers. Sisram Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sisram Medical stock

Free Cash Flow to Debt Ratio of Sisram Medical is 13.17 % in 2025.

Free Cash Flow to Debt Ratio of Sisram Medical changed from 8.97 % to 13.17 %, representing a 46.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Sisram Medical since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Sisram Medical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Sisram Medical

All Key Metrics — Sisram Medical